Literature DB >> 11418685

Gi-mediated activation of the Syk kinase by the receptor mimetic basic secretagogues of mast cells: role in mediating arachidonic acid/metabolites release.

I Shefler1, R Sagi-Eisenberg.   

Abstract

Syk kinase is essential for FcepsilonRI-mediated signaling and release of inflammatory mediators from mast cells. We now show that activation of rat peritoneal mast cells by the nonimmunological, G(i)-mediated pathway also results in the activation of Syk. We show that compound 48/80 (c48/80), a receptor analogue that activates directly G proteins, activates Syk in a pertussis toxin-sensitive fashion. We further show that Syk activation by c48/80 is blocked by the protein kinase C inhibitor GF109203X, by the phosphatidylinositol 3-kinase inhibitors, wortmannin and LY294002, by EGTA, and by the selective src-like kinase inhibitor PP1. These results suggest that in the nonimmunological, G(i)-mediated pathway, Syk is located downstream from phospholipase C and phosphatidylinositol 3-kinase. However, in common with the FcepsilonRI-mediated pathway, activation of Syk by c48/80 is dependent on a src-like protein tyrosine kinase. Finally, we show that in the nonimmunological pathway, Syk plays a central role in the release of arachidonic acid/eicosanoid metabolites, but not in the release of prestored mediators such as histamine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418685     DOI: 10.4049/jimmunol.167.1.475

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Syk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages.

Authors:  Haein Park; Dianne Cox
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

Review 2.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

3.  Mast cell degranulation activates a pain pathway underlying migraine headache.

Authors:  Dan Levy; Rami Burstein; Vanessa Kainz; Moshe Jakubowski; Andrew M Strassman
Journal:  Pain       Date:  2007-04-24       Impact factor: 6.961

4.  In vivo pharmacological evaluation of compound 48/80-induced airways oedema by MRI.

Authors:  H Karmouty-Quintana; F-X Blé; C Cannet; S Zurbruegg; J R Fozard; C P Page; N Beckmann
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

5.  A Mast Cell Degranulation Screening Assay for the Identification of Novel Mast Cell Activating Agents.

Authors:  Herman F Staats; Shaun M Kirwan; Hae Woong Choi; Christopher P Shelburne; Soman N Abraham; Gulice Y C Leung; David Y-K Chen
Journal:  Medchemcomm       Date:  2013-01-01       Impact factor: 3.597

6.  Mast cells modulate the inflammatory process in endotoxin-induced uveitis.

Authors:  Pierre Sebastião da Silva; Ana Paula Girol; Sonia M Oliani
Journal:  Mol Vis       Date:  2011-05-08       Impact factor: 2.367

7.  Allergic Airway-Induced Hypersensitivity Is Attenuated by Bergapten in Murine Models of Inflammation.

Authors:  Douglas B Aidoo; David D Obiri; Newman Osafo; Aaron O Antwi; Leslie B Essel; Babatunde M Duduyemi; Martins Ekor
Journal:  Adv Pharmacol Sci       Date:  2019-02-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.